Abstract 4846 Myelodysplastic syndrome (MDS) is heterogeneous clonal hematopoietic
stem cell disorder characterized by cytopenia (s) and dysplasia in one or more cell lineage …

Background Myelodysplastic syndromes (MDS) are a heterogeneous group of
hematopoietic disorders diagnosed using morphologic and clinical findings supported by …

Background: Myelodysplastic syndromes (MDS) are a heterogeneous group of
hematopoietic disorders, which can be difficult to diagnose based only on morphologic bone …

The myelodysplastic syndromes are a group of clonal hematopoietic stem cell diseases
characterized by cytopenia (s), dysplasia in one or more cell lineages and increased risk of …

Introduction: Myelodysplastic syndrome (MDS) comprises a heterogeneous group of clonal
hematopoietic stem cell diseases with variable clinical course and risk of evolution to acute …

The application of flow cytometry (FC) is recommended as part of the diagnostic approach
for MDS. The complexity of flow cytometric analysis of bone marrow cells in MDS has been …

Background: Myelodysplastic syndromes (MDSs) are a heterogeneous group of bone
marrow disorders. Morphology may be difficult to evaluate in some patients, either due to …

Flow cytometry (FCM) is being increasingly evaluated for the diagnosis of myelodysplastic
syndrome (MDS). We employed multiple FCM approaches to assess MDS. Five-color FCM …

This review focuses on the most recent literature concerning flow cytometry (FCM)
application for diagnosis of myelodysplastic syndrome (MDS). Aberrant FCM results have …

Introduction: The myelodysplastic syndrome (MDS) is a monoclonal stem cell disease which
may cause peripheral cytopenias such as anaemia, thrombocytopenia and neutropenia …